Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lighton | Paris | 40.1% | €87.10M | 0.01 | €14.12 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||||
Orinoquia Real Estate SOCIMI | Paris | Real Estate | Residential & Commercial REITs | 14.3% | €22.83M | 26.4x | €1.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Gaztransport et Technigaz SA | Paris | Energy | Oil & Gas Related Equipment and Services | 11.2% | €4.95B | 17.1x | 0.19 | €133.40 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.9% Upside | Upgrade to Pro+ | |
Hydro Exploitations | Paris | Utilities | Electrical Utilities & IPPs | 7.3% | €14.51M | 10x | 0.01 | €118 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Courtois | Paris | Real Estate | Real Estate Operations | 2.6% | €8.68M | -30.3x | 1.12 | €120 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IDI | Paris | Financial | Investment Banking & Investment Services | 2% | €482.10M | -402.4x | €67.60 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.1% Upside | Upgrade to Pro+ | ||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | -1.3% | €191.06M | 8.6x | 0.05 | €3.75 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | -8.6% | €173.81M | 3.7x | 0.02 | €7.97 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DBV Technologies | Paris | Healthcare | Pharmaceuticals | -13.7% | €63.69M | -0.7x | -1.13 | €0.67 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | -26.8% | €509.22M | -2.5x | -1.62 | €7.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | -30.5% | €146.48M | -3.9x | -0.08 | €3.09 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |